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Abstract
Marine n-3 long-chain PUFA (n-3 LCPUFA) may have a beneficial effect on several aspects of the metabolic syndrome (dyslipidaemia, insu-
lin resistance, hypertension and abdominal obesity). The metabolic syndrome is increasing in prevalence during adolescence, but only few
studies have investigated the effects of n-3 LCPUFA in adolescence. The present study examines associations between fish intake (assessed
by a 7 d pre-coded food diary), erythrocyte (RBC) DHA status (analysed by GC) and metabolic syndrome measures (anthropometry, blood
pressure and plasma lipids, insulin and glucose) in 109 17-year-old children from the Copenhagen Birth Cohort Study. Of the children, 8 %
were overweight or obese and few showed signs of the metabolic syndrome, but all the metabolic syndrome variables were correlated.
Median fish intake was 10·7 (interquartile range 3·6–21·2) g/d. Boys tended to have a higher fish intake (P¼0·052), but girls had signifi-
cantly higher RBC levels of DHA (P¼0·001). Sex and fish intake explained 37 % of the variance in RBC-DHA (P,0·001). After adjusting for
confounders, high DHA status was found to be significantly correlated with higher systolic blood pressure (P¼0·014) and increased fasting
insulin (P¼0·018), but no adverse association was observed with the mean metabolic syndrome z-score. Overall, the present study showed
the expected association between fish intake and RBC-DHA, which in contrast to our expectations tended to be associated with a poorer
metabolic profile. Whether these results reflect the physiological function of n-3 LCPUFA, lifestyle factors associated with fish intake in
Denmark, or mere chance remains to be investigated.
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The incidence of metabolic dysregulation is an increasing
problem, now even occurring during adolescence. Metabolic
dysregulation is characterised by dyslipidaemia, insulin resist-
ance, hypertension and abdominal obesity – the so-called
metabolic syndrome – which predisposes toward the devel-
opment of CVD and type 2 diabetes. Dietary n-3 long-chain
PUFA (n-3 LCPUFA) from marine foods have in adults been
shown to have a beneficial effect on blood pressure (BP)(1)
and blood lipid profile, specifically plasma TAG(2).
Furthermore, n-3 LCPUFA have been shown to prevent the
development of insulin resistance induced by a high-fat or
high-sucrose diet in rodents(3,4). Some studies have shown
associations between n-3 LCPUFA and better insulin sensitivity
in human subjects(5,6) and recent randomised trials have also
shown beneficial effects of fish oil supplementation(7–10).
However, the results concerning the relationship between
n-3 LCPUFA and insulin sensitivity in human subjects are not
at present convincing(11,12). A possible explanation for the
inconsistencies could be that the effect may be different in
established insulin resistance and during its development.
It is at present believed that infants have higher needs for
n-3 PUFA due to their effect on the development of the central
nervous system(13). In Denmark, it is recommended that
infants ingest a minimum of 1 % of their energy (percentage
of energy; E%) as n-3 PUFA, as opposed to 0·5 E% from
2 years of age. We have previously shown that fish oil sup-
plementation of 9-month-old infants have a beneficial effect
on plasma lipid profile and BP(14). This result surprised us
since the infants had an overall low cardiovascular risk profile
and the adult studies tend only to find an effect of fish oil in
subjects with a high risk profile(1). It is our hypothesis that
the results could reflect a greater susceptibility towards effects
of n-3 LCPUFA intake in the infant growth phase due to a
higher n-3 PUFA need and that effects of n-3 LCPUFA intake
would also be detectable in other growth phases and on
other characteristics of the metabolic syndrome.
*Corresponding author: Dr Lotte Lauritzen, fax þ45 3533 2483, email ll@life.ku.dk
Abbreviations: BP, blood pressure; E%, percentage of energy; FA%, percentage of all fatty acids in the chromatogram; HDL-C, HDL-cholesterol; HOMA-IR,
homeostasis model assessment of insulin resistance; LCPUFA, long-chain PUFA; RBC, erythrocyte; SBP, systolic blood pressure.
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In the present study, we examined if n-3 LCPUFA status or
intake in adolescents was associated with biomarkers of the
metabolic syndrome in a cross-sectional analysis within the
prospective Copenhagen Birth Cohort Study. The prospective
design enabled us to take prognostic variables (for example,
birth weight, duration of breast-feeding and socio-economic
factors) into account as well as possible confounding lifestyle
factors (diet and physical activity). Furthermore, we examined
associations between erythrocyte (RBC) n-3 LCPUFA and
fish intake.
Methods
The Copenhagen Cohort Study is a prospective observational
study where a random sample of Danish infants born from
1987 to 1988 was followed during the first year of life and
later followed up at 10 and 17 years. The inclusion criteria
were: parents of Danish origin, singleton birth, 37–42
weeks’ gestation, normal birth weight (10th–90th percentiles
for gestational age), no neonatal disease or malformation. Of
the 251 infants who fulfilled the inclusion criteria, 145 infants
completed the study, fifty-nine of which were in a control
group only examined at 9 months, whereas the rest
were examined several times during the first year of life(15).
They were all invited to take part in this 17-year follow-up
and 109 (75 %) agreed to participate. The present study was
conducted according to the guidelines laid down in
the Declaration of Helsinki and was approved by the Ethics
Committee for Copenhagen and Frederiksberg (no. KF
01-226/97). Written informed consent was obtained from
all participants and their parents.
Dietary intake was determined in the week before the
examination visit by a 7 d food record with pre-coded
response categories and open supplementary alternatives as
previously described(16). Intake was registered in household
measures and portion sizes based on an accompanying
photograph series. From these records, intake of energy,
macronutrients and micronutrients and that of specific food
categories (fish, meat, dairy products, fruits and vegetables,
cereals and sweets) was calculated using the national food
database. Fish intake was assessed by twelve individual vari-
ables; six for lunch and six for dinner which distinguished
between fatty and lean fish and seafood: lean fish for
dinner, fatty fish for dinner, fish balls, sushi, fish stews,
shrimps as main course, sandwich with breaded fillet of sole
or similar, tuna in salad or on bread, herring, mackerel and
other kinds of fatty fish on bread, cod roe, and seafood as
main dish or garnish. Physical activity was determined by a
24 h recall questionnaire (habitual activity estimation scale)
as previously described(17).
Height was measured to the nearest 1 mm by a stadiometer
(Chasmore, London, UK) and weight was measured to the
nearest 0·1 kg by an electronic scale (Lideltronic 8000; Lindells
Inc., Kristianstad, Sweden). Waist and hip circumferences
were measured in triplicate according to standard procedures.
Body fat percentage was determined by dual-energy X-ray
absorptiometry on a Hologic QDR 1000/W with software ver-
sion 5.73 (Hologic Inc., Waltham, MA, USA). Brachial BP was
assessed after 10 min of supine rest by oscillometry using the
average of three BP recordings.
RBC isolated from a fasting heparinised blood sample was
used to assess the RBC fatty acids composition by GLC as
previously described(18). Fatty acid composition is given as
the percentage of individual fatty acids relative to the total chro-
matogram (FA%). Metabolism ratios were calculated by ratios
between the fatty acids immediately before a D6-desaturation
step and those after (also including the last elongation and
post-desaturation oxidation step in the LCPUFA synthesis,
18 : 2n-6:18 : 3n-6, 18 : 3n-3:18 : 4n-3, 22 : 4n-6:22 : 5n-6, 22 : 5n-
3:22 : 6n-3 and the combined ratio).
Total cholesterol, HDL-cholesterol (HDL-C) and TAG concen-
trations of fasting EDTA plasma were measured with enzymic
kits from Roche (CHOD-PAP, HDL-C-plus 2nd generation,
and GPO-PAP, respectively) on a Cobas Mira Plus analyser
(Roche Diagnostic, Basel, Switzerland). The LDL-cholesterol
concentrations were calculated using the Friedewald
formula(19). Fasting glucose was measured with the use of the
hexokinase endpoint method (Gluco-quant Glucose/HK;
Roche Diagnostics, Basel, Switzerland) using an ABX Pentra
400 chemistry analyser (ABX Pentra, Horiba ABX, Montpellier,
France). Fasting serum insulin was measured by a solid-phase,
two-site chemiluminescent immunometric assay with the use
of an Immulite 1000 analyzer (Diagnostic Products Corp., Los
Angeles, CA, USA). Homeostasis model assessment of insulin
resistance (HOMA-IR) was calculated by the HOMA2 model
using the HOMA Calculatorq (version 2.2.2; University of
Oxford, 2004, http://www.dtu.ox.ac.uk/homacalculator/). We
used standard adult cut-offs according to the American National
Institute of Health’s National Cholesterol Education Program(20)
to determine the presence of the metabolic syndrome using
three out of the five following criteria: waist . 102 cm for
boys and . 88 cm for girls, plasma TAG . 1·7 mmol/l, HDL-
C , 0·9 mmol/l for boys and , 1·0 mmol/l for girls,
glucose . 6·1 mmol/l and BP . 130/85 mmHg. Furthermore,
for each of the metabolic syndrome variables (waist, systolic
BP (SBP), TAG, HDL-C and HOMA-IR) z-scores were calculated
based on the mean and the standard deviation in the relevant
sex subgroup of the participants in such a way that a positive
z-score for all variables indicates higher risk. A combined meta-
bolic syndrome z-score was calculated as the mean of the
z-scores of all metabolic syndrome variables (the z-score of
HDL-C was used with an opposite sign since a high HDL-C
concentration is considered beneficial).
Statistics
All statistical analysis was performed by SPSS 16.0 (SPSS Inc.,
Chicago, IL, USA). Normal distribution of all variables was
checked by Kolmogorov–Smirnov and by visual inspection
of histograms. The following variables were not normally dis-
tributed and thus log-transformed before analysis: plasma
cholesterol, TAG, RBC 20 : 3n-9, RBC-EPA, intake of energy,
fish, Na, dietary fibres and sugar. Fasting insulin was used as
a reverse value. All descriptive results are given as mean
values and standard deviations or median (25th and 75th per-
centile) and outcome parameters are given as mean values
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with their standard errors. Group comparisons (participants
v. non participants and boys v. girls) were performed by
Student’s t test or, for non-normally distributed variables, by
the Mann–Whitney U test. Associations between fish intake
(total or individual fish intake parameters) and RBC n-3
LCPUFA were checked by backward multiple regression anal-
ysis and the final model was chosen as the one with maximum
explained variance and the fewest independent variables. The
participants were divided in tertiles according to RBC-DHA
status with an even distribution of girls and boys by a separate
division of boys and girls and a subsequent pooling of the
sex subgroups in each of the tertiles. Associations between
RBC-DHA status (high, medium and low as determined by ter-
tiles in the population) and various outcome parameters (diet,
body composition parameters, and the other metabolic syn-
drome variables) were assessed by logistic regression analysis.
All models were adjusted for sex, duration of breast-feeding
and diet (and body composition for all non-body composition
variables) plus for the individual blood lipids with further
adjustment of the corresponding blood lipid during the first
year of life (mean of values at 2, 4 and 9 months). Outcomes
that were found to be significantly associated with RBC-DHA
status were also analysed in relation to RBC-DHA as a continu-
ous variable and the same adjustments.
Results
The 109 children, who took part in this follow-up substudy,
were examined at a mean age of 17·3 (SD 0·2) years.
The characteristics of the included children are shown in
Table 1. The participating children did not differ from the
non-participating children with respect to any of the given
characteristics (data not shown). Only approximately 8 %
of the children were overweight or obese according to waist
circumference cut-offs or BMI and few exceeded the cut-off
for one or more of the other metabolic syndrome criteria:
nine had high plasma TAG, eleven had low HDL-C (four of
whom also had high TAG), seven had total plasma
cholesterol . 5 mmol/l, none were hypertensive, five had
SBP . 130 mmHg, and none was hyperglycaemic. Of the chil-
dren, two had the metabolic syndrome according to the ‘three
out of five’ National Cholesterol Education Program defi-
nition(20). There were significant (sex-adjusted) bivariate
associations between all of the metabolic syndrome variables.
Table 2 gives the overall fatty acid composition of the RBC
of the children. Girls had significantly higher levels of
DHA and the PUFA composition generally points to a better
D6-desaturation capacity with a significant lower ratio
between pre- and post-D6-desaturase fatty acids (2·4 (SD 0·5)
v. 3·0 (SD 0·7) in boys; P,0·001), especially the 22 : 5n-
3:DHA ratio (0·4 (SD 0·1) v. 0·6 (SD 0·1); P,0·001). After adjust-
ment for fish intake, RBC-DHA status was estimated to be 1·0
(SD 0·2) FA% (P,0·001) higher in girls.
Median fish intake was 10·7 (interquartile range 3·6–21·2)
g/d and tended to be higher in boys (14·3 v. 8·0 g/d in girls;
P¼0·052; Mann–Whitney). Overall, fish intake was distributed
as follows: 21 % of the total amount of fish came from fatty fish
for dinner, 25 % from dishes with lean fish for dinner, 9 % from
mixed fish dishes (sushi, etc.), 10 % from fatty fish sandwiches
for lunch, 10 % from sandwiches with lean fish and 14 % from
seafood – maximally 14 % of the fish was breaded. There was
a significant association between the intake of fish at 17 years
and that at 10 years (r 0·195; P¼0·007; n 92) and also a slight
tendency towards an association with intake of fish at 9 months
of age (r 0·124; P¼0·101; n 91).
RBC-DHA was correlated with total fish intake adjusted for
sex (r 0·488; P,0·001) and so was the RBC content of n-3
LCPUFA (r 0·341; P¼0·001). Of the variance in RBC-DHA,
Table 1. Characteristics of the participating 17-year-old boys and girls
(Mean values and standard deviations or medians and 25th–75th percentiles)
Boys Girls
Mean SD Mean SD P
Subjects (n) 44 65
Birth weight (kg) 3·52 0·38 3·36 0·35 0·021
Length at birth (cm) 52·1 1·8 51·2 2·0 0·296
Duration of breast-feeding (months) 0·454
Median 5·0 7·0
25th–75th percentile 2·0–8·8 3·0–9·0
Intake of fish at 9 months (g/d) 0·381
Median 2·9 1·6
25th–75th percentile 0–11·8 0–7·6
Maternal BMI (kg/m2) 20·9 2·6 21·5 2·8 0·298
Paternal BMI (kg/m2) 23·6 3·0 23·8 2·7 0·773
Maternal smoking in first year (cigarettes/d) 0·540
Median 3 0
25th–75th percentile 0–12 0–12
Mean plasma cholesterol in first year (mmol/l) 4·1 0·6 4·3 0·7 0·192
Mean LDL-cholesterol in first year (mmol/l) 2·1 0·7 2·6 1·2 0·052
Mean HDL-cholesterol in first year (mmol/l) 0·98 0·26 1·28 1·25 0·239
Mean TAG in first year (mmol/l) 2·2 1·1 1·7 0·6 0·019
Height at 17 years (m) 1·83 0·06 1·67 0·06 ,0·001
Weight at 17 years (kg) 72·6 10·6 59·4 10·6 ,0·001
BMI at 17 years (kg/m2) 21·62 3·05 21·30 3·15 0·597
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37 % was explained by sex and the last week’s fish intake, with
the most significant contributions from lean fish for dinner,
tuna, sushi, sole fillet sandwich, fish balls, and fatty fish for
dinner. Inclusion of the overall intake of PUFA (essentially
equivalent to that of linoleic and a-linolenic acids) did not
change this pronouncedly (39 % explained variance).
When divided according to RBC-DHA status by sex-adjusted
tertiles, the RBC-DHA groups were found to differ significantly
with respect to duration of breast-feeding, but not in any of
the other prognostic or lifestyle-dependent variables at birth
(Table 3). Furthermore, sex-adjusted dietary intake in the
high, medium and low RBC-DHA status groups differed sig-
nificantly with respect to PUFA E% (P¼0·041) and there was
a tendency towards a difference in the Na intake (P¼0·077)
and the protein:carbohydrate ratio of the diet (P¼0·123).
The RBC-DHA groups did not differ significantly with respect
to parental BMI (data not shown) or body composition in
analysis adjusted for sex, breast-feeding and dietary factors
(total energy intake, PUFA E% and protein:carbohydrate)
(Table 4). However, after adjusting for sex, breast-feeding,
dietary factors and body fat percentage there were significant
differences in SBP and fasting insulin and tendencies in
HOMA-IR, heart rate and plasma total cholesterol after further
adjustment for plasma cholesterol during first year of life
(Table 4). The degree of explained variance in the models
was 20–30 % for the HOMA-IR and insulin parameters,
about 20 % for the blood lipids, and 43 % for SBP. The overall
outcome of these analyses was not changed by inclusion of
physical activity or food patterns (for example, intake of
fruits and vegetables). SBP was also associated with RBC-
DHA as a continuous variable in a multiple regression analysis
including the same adjusting factors as above (B ¼ 1·7 (SEM
0·6) mmHg/FA% (P¼0·005) and HOMA-IR tended to be
associated with RBC-DHA as well (P¼0·052)). However, no
association was observed between RBC-DHA and the mean
metabolic syndrome z-score (P¼0·60). The overall picture
and conclusions were the same (although less significant) in
similar analyses with RBC-EPA and fish intake.
Table 2. Fatty acid composition of erythrocytes from 17-year-old boys
and girls*
(Mean values and standard deviations)
Boys Girls
Mean SD Mean SD P
Subjects (n) 44 65
SFA 41·1 0·55 41·3 0·90 0·175
MUFA 17·1 0·83 16·8 0·82 0·066
18 : 2n-6 10·8 1·15 10·2 0·99 0·003
18 : 3n-3 0·19 0·05 0·18 0·04 0·784
20 : 2n-6 0·24 0·03 0·26 0·04 0·014
20 : 3n-9 0·11 0·03 0·11 0·02 0·835
20 : 3n-6 1·97 0·38 1·94 0·41 0·686
20 : 4n-6 15·5 1·34 15·7 0·98 0·324
20 : 5n-3 0·79 0·28 0·74 0·32 0·160
22 : 4n-6 3·16 0·60 3·21 0·59 0·632
22 : 5n-6 0·61 0·13 0·70 0·23 0·008
22 : 5n-3 2·73 0·21 2·31 0·31 0·001
22 : 6n-3 4·99 1·21 5·82 0·99 0·001
PUFA 41·3 0·93 41·43 0·93 0·390
n-3 Long-chain PUFA 8·62 1·51 9·00 1·23 0·152
n-6:n-3 PUFA 3·70 0·78 3·50 0·61 0·161
* Values are given as the percentages of individual fatty acids relative to the total
chromatogram area (FA%).
Table 3. Diet and lifestyle at 17 years of age and infant characteristics in sex-adjusted tertiles according to erythro-
cyte DHA status
(Mean values with their standard errors or medians and 25th–75th percentiles)
Tertile. . . Low Medium High
Mean SEM Mean SEM Mean SEM P
Subjects (n) 36 37 36
Sex (% girls) 58 62 58
Birth weight (kg) 3·35 0·06 3·50 0·06 3·41 0·06 0·227
Duration of breast-feeding (months) 0·002
Median 4 5 9
25th–75th percentile 1–8 3–8 5–9
Fish intake at 9 months (g/d) 0·276
Median 0 1 4
25th–75th percentile 0–4 0–10 0–11
HAES physical activity score 4·1 0·2 4·1 0·2 3·8 0·2 0·333
Energy intake (MJ/d) 9·3 0·5 10·2 0·6 10·4 0·6 0·122
Carbohydrate (E%) 53·1 0·7 51·3 0·8 52·1 0·7 0·314
Protein (E%) 13·1 0·3 13·9 0·3 13·9 0·4 0·137
Fat (E%) 30·9 0·8 32·0 0·8 31·7 0·6 0·419
Fish and fish products (g/d) 8 2 16 3 23 3 0·001
Girls (g/d) 8 3 10 2 20 4
Boys (g/d) 8 2 25 8 27 6
Meat and poultry (g/d) 136 9 142 10 142 9 0·539
Dairy products (g/d) 461 64 461 83 452 64 0·916
Fruits and vegetables (g/d) 532 48 423 32 596 72 0·462
Cereals and bread (g/d) 210 13 238 15 246 18 0·082
Fats (g/d) 30 3 33 3 36 4 0·193
Sweets and sugar products (g/d) 50 5 44 4 51 5 0·911
HAES, habitual activity estimation scale; E%, percentage of energy.
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Discussion
The results of the present study showed that teenage girls
have higher levels of DHA in their RBC than boys and that
fish intake in both sexes was strongly associated with RBC
n-3 LCPUFA status. In contrast to our expectations, higher
RBC-DHA was not found to be associated with lower markers
of the metabolic syndrome, but rather a higher BP and lower
insulin sensitivity compared with adolescents with a lower
RBC DHA status. However, after adjustment for confounders,
no adverse association was observed with the mean metabolic
syndrome z-score.
The positive association between intake of fish and RBC n-3
LCPUFA status was in accordance with our expectations.
Intake of fish explained approximately 40 % of the variation
in RBC-DHA, which is in accordance with that in previous
studies, for example, in pregnant women(21). To our knowl-
edge, no studies have verified the fish intake–RBC biomarker
relationship in children, but the present study indicates only
minor potential for effect modification by age and sex. The
low degree of explained variance may primarily be because
the periods of diet registration were short compared with
the day-to-day variation in fish intake. Furthermore, the 7 d
food record was only semi-quantitative. The uncertainty of
the present study is therefore presumed to be mainly related
to the dietary registration, while assessment of RBC n-3
LCPUFA is considered a stable measure of fish intake during
the last couple of months. We therefore believe that RBC
n-3 LCPUFA is the most relevant measure to use when associ-
ations with the functional outcomes are examined. Surpris-
ingly, we found that intake of lean fish had a significant
impact on DHA status at 17 years. This could be explained
by the fact that the fish intake in this group of teenagers
was relatively low (approximately half the amount compared
with Danish adults) and primarily consumed for dinner
(66 % was fish for dinner), which typically consists of lean
fish in Denmark while fatty fish such as herring and mackerel
more often are consumed for lunch. Although the average fish
intake in this group of adolescents is low, the range of fish
intake was quite wide (total intake of fish ranged between 0
and 120 g/d) and spans the whole spectrum of fish intake
that has previously been reported to have beneficial effects.
The surprising adverse association between fish intake and
some metabolic syndrome markers in the present study may
be explained by high fast food intakes (for example, fish
and chips) during adolescence. However, that was not sup-
ported by the food records. Furthermore, breaded fish filets
also contributed to the DHA status, which probably means
that the filets were only lightly breaded and not deep-fried,
since most of the fat in commercially breaded deep-fried
fish products would be SFA, MUFA and n-6 PUFA. It has
been hypothesised that intake of linoleic acid relative to that
of PUFA may blunt the tissue incorporation of n-3
LCPUFA(22). However, adjustment for intake of PUFA did not
play a role in relation to the association between fish intake
and RBC-DHA. This is in agreement with the incorporation
Table 4. Metabolic syndrome variables at 17 years of age in sex-adjusted tertiles according to erythrocyte
DHA status
(Mean values with their standard errors or medians and 25th–75th percentiles)
Tertile. . . Low Medium High
Mean SEM Mean SEM Mean SEM P *
Subjects (n) 36 37 36
Height (m) 1·74 0·02 1·72 0·02 1·74 0·02 0·662
Weight (kg) 64·4 1·8 62·4 2·0 67·5 2·3 0·252
BMI (kg/m2) 21·3 0·5 20·9 0·4 22·1 0·6 0·332
Waist circumference (cm) 79·0 1·4 77·1 1·4 80·2 1·8 0·734
Body fat (%) 20·9 1·4 20·3 1·0 22·7 1·3 0·319
Fasting glucose (mmol/l) 4·48 0·06 4·52 0·05 4·56 0·06 0·649
Fasting insulin (pmol/l) 0·018
Median 51 52 62
25th–75th percentile 40–67 43–78 49–86
HOMA-IR 1·03 0·09 1·02 0·07 1·44 0·21 0·052
Diastolic blood pressure (mmHg) 53·5 0·8 52·5 0·9 54·5 1·0 0·333
Systolic blood pressure (mmHg) 113·8 1·4 113·6 1·3 117·9 1·4 0·014
Heart rate (beats per min) 63·7 9·3 63·2 7·8 69·0 8·5 0·062
Cholesterol (mmol/l) 0·064
Median 3·31 3·42 3·58
25th–75th percentile 2·93–3·90 3·16–4·06 3·15–4·12
LDL-cholesterol (mmol/l) 2·26 0·18 2·23 0·10 2·37 0·11 0·365
HDL-cholesterol (mmol/l) 1·29 0·05 1·46 0·05 1·46 0·07 0·287
TAG (mmol/l) 0·474
Median 0·86 0·89 0·87
25th–75th percentile 0·62–1·12 0·61–1·13 0·66–1·06
Mean MS z-score 0·01 0·09 20·18 0·05 0·04 0·09 0·958
HOMA-IR, homeostasis model assessment of insulin resistance; MS z-score, mean metabolic syndrome z-score;
* The statistical analysis of anthropometric variables was adjusted for sex, duration of breast-feeding and diet (percentage of
energy from PUFA and proteins:carbohydrates ratio). These covariates were also used in the models for the other meta-
bolic syndrome markers along with body fat percentage, and blood lipids in the first year for plasma lipids and intake of Na
for blood pressure.
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results from a recent two-factorial trial where we supple-
mented adult men simultaneously with both n-3 LCPUFA
and linoleic acid(23); nevertheless, such an effect has been
shown in plasma from children(24). Interestingly, this cohort
study results show significant associations between fish
intake throughout childhood, indicating stability in the dietary
pattern and validity in the dietary assessments. This, however,
also means that we cannot distinguish between whether the
associations we found between status and health reflect a
relationship with the present fish intake or a programming
effect. The observed association between duration of
breast-feeding and DHA status at 17 years of age could be a
programming effect but is more likely due to lifestyle associ-
ations (between breast-feeding and fish intake). No significant
association was observed of breast-feeding on RBC fatty acid
composition after adjustment for sex and fish intake (data
not shown).
Previous studies have shown that fish oil lowers plasma
TAG and BP, although the effect on BP only seems to occur
among people who have an unfavourable risk profile(1) and
among infants(14). Furthermore, it has been shown that n-3
PUFA inhibit development of obesity and insulin resistance
induced by a high-fat and -sucrose diet in rodents(3,4).
A high serum n-3 PUFA status has also in adult men been
shown to decrease the relative risk for developing the meta-
bolic syndrome over the following 20 years, independent of
smoking habits, physical activity and BMI(25). Much to our
surprise, the present cross-sectional study showed a poten-
tially inverse relationship between DHA status and BP and
insulin sensitivity in adolescents. A lack of an association
might be anticipated due to lack of power, the overall health
status of the subjects or too low a dose. However, we have
previously in a follow-up study to a randomised controlled
trial with fish oil supplementation during lactation seen similar
adverse long-term effects on BP(26), but this is in contrast to
the programming effect of perinatal intake of n-3 PUFA
observed in rodents(27) and formula-fed infants(28). The chil-
dren in our randomised controlled trial were also healthy
Danish adolescents, but the n-3 LCPUFA dose was in the
higher end of the population intake range and the difference
in intake was limited to a period of the first 4 months of lacta-
tion. Most of the children in the present study had BP, plasma
lipid profile and markers of glucose homeostasis within the
normal range and the overall negative effects were small.
The long-term implications may, however, be clinically rel-
evant as these risk markers have been shown to track and a
high value could then translate into a clinically increased
level later in life. The observed adverse associations could in
theory be due to various pollutants in the fish(29). The fish
intake in the examined population was, however, not very
high and other studies have also found beneficial association
between plasma levels of marine pollutants and CVD risk fac-
tors, indicating that the benefits outweigh the potential
risks(30). Fish intake is typically related to a healthy diet and
lifestyle and in the present study there was also a positive
correlation with intake of fruit and vegetables, indicating
that fish consumption is also related to a generally
healthy diet among these teenagers, which makes the lack
of a beneficial association between RBC-DHA and markers
of the metabolic syndrome even more odd. It seems implausi-
ble that the active components of a healthy diet should
have markedly different physiological effects in teenagers
compared with in adults. The adverse relationship between
RBC-DHA and BP and markers of insulin sensitivity could,
however, be due to hidden confounding factors that we did
not measure or that other aspects of the teenage lifestyle
were unhealthy – too much food and too little physical
activity. Inclusion of the possible confounding factors that
we did have information on (for example, physical activity
and intake of fruits and vegetables) did not affect the adverse
association. We have also taken the protein:carbohydrate ratio
in the diet into account, as this has been found to modulate
the effect of PUFA in rats(31,32). This factor played a significant
role for some of the outcomes but not as an effect modifier of
the effect of DHA status.
There was a significant difference in the RBC fatty acid
composition between boys and girls, with higher DHA levels
in girls in spite of a lower fish intake. There was also a signifi-
cant higher RBC incorporation of 22 : 5n-6, the n-6 LCPUFA
synthesis endproduct, and a lower RBC D6-desaturase substra-
te:product-ratio, specifically in the ratio between 22 : 5n-3 and
DHA. Thus, overall, the sex difference could reflect a higher
D6-desaturase capacity in girls. This is the first study to
show sex differences in PUFA levels in adolescents, but
similar differences in fatty acid composition have previously
been observed in blood lipids of men and women(33–35).
Furthermore, women have been shown to have a higher
rate of conversion from a-linolenic acid to n-3 LCPUFA(36).
Sex differences have also been observed in the tissue fatty
acid composition in rats, but Burdge et al. found no sex
difference in rat hepatic D6-desaturase expression and no
association between the proportion of individual PUFA in hepa-
tic phospholipids and D6- or D5-destaurase expression(37–39).
Genetic differences in fatty acid desaturase (FADS) 1–2, the
gene cluster that codes for D5- and D6-desaturases in man,
have been shown to be reflected in tissue PUFA levels, mostly
so in the variation in 20 : 2n-6 and 20 : 4n-6 (arachidonic
acid)(40,41). The final LCPUFA synthesis step to DHA and
22 : 5n-6 involves more than a D6-desaturation and it could be
these other steps that were up-regulated. What ever the
mechanism, tissue PUFA composition has been found to be
manipulated by sex hormones(33,36,42). The fact that girls have
a higher endogenous capacity for synthesis of DHA could
presumably mean that they were less dependent or less affected
by intake. This idea is in line with the fact that people with a high
genetically determined capacity (a specific allele composition in
the FADS2 gene) have been shown to be less affected by intake
– for example, the effect of breast-feeding v. formula feeding on
intelligence quotient (IQ)(43).
This is among the first studies to examine the relationship
between intake of fish and n-3 LCPUFA on markers of
health in adolescents. The strength of our cohort study is
that it had an initial random selection and a relatively high
rate of follow-up (i.e. 75 % of all the children who were
recruited at birth). However, since it is an observational
study we cannot exclude that our findings could be due to
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residual confounding or atypical associations between fish
intake and lifestyle in this particular group of teenagers. In
summary, the results from this cross-sectional analysis in our
cohort showed that sex and fish intake explain much of the
variance in adolescent RBC-DHA status, boys tend to have
a higher fish intake, but girls had higher RBC-DHA status.
Furthermore, in contrast to expectations, DHA status was
found to be associated with higher BP and lower insulin sen-
sitivity, but not with the overall metabolic syndrome z-score.
Whether these results are a mere chance finding or whether
they reflect a truly different effect of n-3 LCPUFA during
growth needs to be investigated by more studies, preferably
intervention studies, on the relationship between n-3
LCPUFA intake and health in adolescence.
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